cro.directory
← Compare landing

Cisema vs ProPharma Group

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryCisemaProPharma Group
SummaryCisema supports medical device, IVD, pharmaceutical, and cosmetics companies with NMPA-related product registration, China device clinical studies, and local authorized representative services across China and Asia Pacific. Its offerings also include vigilance and post-market surveillance, quality compliance, and reimbursement market access work.ProPharma Group provides pharmacovigilance, regulatory sciences, medical information, medical writing, and biostatistics services to life sciences companies. Its regulatory offering covers FDA and European work, including an AI-assisted capability for ANDA submission development.
Services
  • Clinical Trial Services
  • Clinical Operations
  • Pharmacovigilance & Drug Safety
  • Regulatory Affairs
  • China NMPA Regulatory Strategy
  • Clinical Operations
  • Biostatistics & Statistical Programming
  • Pharmacovigilance & Drug Safety
  • Medical Writing
  • Regulatory Affairs
  • US FDA Regulatory Strategy
  • EU EMA Regulatory Strategy
ModalitiesData not yet provided.Data not yet provided.
IndicationsData not yet provided.Data not yet provided.
PhasesData not yet provided.Data not yet provided.
Sourcing modelsData not yet provided.Data not yet provided.
Locations
  • Hong Kong (Headquarters), Hong Kong, Hong Kong
  • Beijing, Beijing, China
  • Tianjin, Tianjin, China
  • Hangzhou, Hangzhou, China
  • Qingdao, Qingdao, China
Data not yet provided.
CertificationsData not yet provided.Data not yet provided.

Find similar companies

Cisema alternatives · ProPharma Group alternatives

Markdown mirror: /compare/cisema/propharmagroup.md